Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
You Lü(Sichuan University), Jianxin Xue(Sichuan University), Tao Deng, Xiaojuan Zhou(Sichuan University), Kun Yu, Lei Deng(Jacobi Medical Center), Meijuan Huang(Sichuan University), Xin Yi, Maozhi Liang(Sichuan University), Yu Wang(Sichuan University), Haige Shen, Ruizhan Tong(Sichuan University), Wenbo Wang(Shanghai Jiao Tong University), Li Li(Sichuan University), Jin Sook Song, Jing Li, Xiaoxing Su(Berry Oncology (China)), Zhenyu Ding(Sichuan University), Youling Gong(Sichuan University), Jiang Zhu(Sichuan University), Yongsheng Wang(Sichuan University), Bingwen Zou(Sichuan University), Yan Zhang(Sichuan University), Yanying Li(Sichuan University), Lin Zhou(Sichuan University), Yongmei Liu(Sichuan University), Min Yu(Sichuan University), Yuqi Wang(Sichuan University), Xuanwei Zhang(Sichuan University), Limei Yin(Sichuan University), Xuefeng Xia, Yong Zeng, Qiao Zhou(Sichuan University), Binwu Ying(Sichuan University), Chong Chen(Sichuan University), Yuquan Wei(Sichuan University), Weimin Li(Sichuan University), Tony Mok(Chinese University of Hong Kong)
Cited by 528
Abstract
Related Papers
No related papers found
Powered by citation graph analysis